Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
KalVista Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 10K | Oct 3, 2024 | Direct | ||
CONCERT PHARMACEUTICALS, INC. | Chief Operating Officer | Common Stock | 0 | $8.33 | Mar 6, 2023 | Direct | |
CONCERT PHARMACEUTICALS, INC. | Chief Operating Officer | Performance Stock Units | 0 | Mar 6, 2023 | Direct | ||
CONCERT PHARMACEUTICALS, INC. | Chief Operating Officer | Stock Option (Right to Buy) | 0 | Mar 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KALV | KalVista Pharmaceuticals, Inc. | Oct 3, 2024 | 1 | $0 | 4 | Oct 4, 2024 | Director |
KALV | KalVista Pharmaceuticals, Inc. | Sep 26, 2023 | 1 | $0 | 4 | Sep 28, 2023 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Mar 6, 2023 | 10 | $0 | 4 | Mar 6, 2023 | Chief Operating Officer |
CNCE | CONCERT PHARMACEUTICALS, INC. | Feb 15, 2023 | 1 | -$50.4K | 4 | Feb 16, 2023 | Chief Operating Officer |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 30, 2023 | 1 | -$110K | 4 | Jan 31, 2023 | Chief Operating Officer |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 6, 2023 | 1 | -$21K | 4 | Jan 9, 2023 | Chief Operating Officer |
KALV | KalVista Pharmaceuticals, Inc. | Oct 13, 2022 | 1 | $0 | 4 | Oct 17, 2022 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Feb 14, 2022 | 1 | -$18.6K | 4 | Feb 16, 2022 | Chief Operating Officer |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 28, 2022 | 2 | $0 | 4 | Feb 1, 2022 | Chief Operating Officer |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jan 5, 2022 | 1 | -$9.23K | 4 | Jan 7, 2022 | Chief Operating Officer |